Literature DB >> 10385129

Improvement of ocular blood flow and retinal functions with puerarin analogs.

B Xuan1, Y H Zhou, R L Yang, N Li, Z D Min, G C Chiou.   

Abstract

Ischemic retinopathy and, particularly, age-related macular degeneration (AMD) are difficult eye diseases to treat. Since the etiology of these diseases is inadequate blood circulation in the retina and choroid, drugs which can improve blood circulation to these tissues should be beneficial to these diseases. Since fovea is avascular, AMD is closely related to choroidal vascular abnormalities, and drugs which show strong effects to increase choroidal blood flow would be particularly useful. Puerarin and all its derivatives, except ET (puerarin disubstituted with -CH2CH2OH), showed marked increase of choroidal blood flow at various time periods. Even ET showed a tendency to increase choroidal blood flow, though it was not statistically significant. As for b wave recovery, all puerarin analogs showed strong recovery of retinal function after ischemic insult for 30 min. These results indicate that puerarin analogs could be used for the treatment of ischemic retinopathy, and AMD in particular.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385129     DOI: 10.1089/jop.1999.15.207

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  11 in total

1.  The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion.

Authors:  Peng-Fei Yue; Xiu-Yun Lu; Zeng-Zhu Zhang; Hai-Long Yuan; Wei-Feng Zhu; Qin Zheng; Ming Yang
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

Review 2.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

3.  Absorptive interactions of concurrent oral administration of (+)-catechin and puerarin in rats and the underlying mechanisms.

Authors:  Hui-fang Su; Qing Lin; Xin-yi Wang; Yao Fu; Tao Gong; Xun Sun; Zhi-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

4.  Protective effect of puerarin on diabetic retinopathy in rats.

Authors:  Yan Teng; Hao Cui; Mingming Yang; Han Song; Qingsheng Zhang; Ying Su; Jianqiu Zheng
Journal:  Mol Biol Rep       Date:  2008-06-28       Impact factor: 2.316

5.  Binding of puerarin to human serum albumin: a spectroscopic analysis and molecular docking.

Authors:  Yang He; Yiwei Wang; Lifei Tang; Hui Liu; Wei Chen; Zhongliang Zheng; Guolin Zou
Journal:  J Fluoresc       Date:  2007-12-06       Impact factor: 2.217

6.  Analysis of the mechanisms underlying the endothelium-dependent antivasoconstriction of puerarin in rat aorta.

Authors:  Li-Ping Yan; Yu-Lan Zhuang; Shun-Wan Chan; Shi-Lin Chen; Gang-Gang Shi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-04       Impact factor: 3.000

7.  EFFECT OF PUERARIN ON THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS AND THE EXPRESSION OF TYPE I COLLAGEN mRNA IN A HIGH-GLUCOSE ENVIRONMENT.

Authors:  X H Wang; X W Shi; X X Luo; D H Zhang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

8.  Measurement of Retinal Blood Flow Using Fluorescently Labeled Red Blood Cells.

Authors:  Tess E Kornfield; Eric A Newman
Journal:  eNeuro       Date:  2015 Mar-Apr

9.  Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.

Authors:  Zhiqun Tan
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-14

10.  Erratum: Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.

Authors:  Zhiqun Tan
Journal:  J Ocul Biol Dis Infor       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.